DIN 02283417 — SOMATULINE AUTOGEL 120 MG
SOMATULINE AUTOGEL is a solution (extended-release) of Lanreotide marketed by IPSEN BIOPHARMACEUTICALS CANADA INC. The full Lanreotide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02283417
- Brand name
- SOMATULINE AUTOGEL
- Active ingredient
- Lanreotide
- Strength
- 120 MG
- Dosage form
- SOLUTION (EXTENDED-RELEASE)
- Route
- SUBCUTANEOUS
- Manufacturer
- IPSEN BIOPHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Somatostatin analogue (antigrowth hormone agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Lanreotide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02555883 | MYTOLAC | 120 MG | SOLUTION (EXTENDED-RELEASE) | ADVANZ PHARMA CANADA INC. | MARKETED |
| 02555867 | MYTOLAC | 60 MG | SOLUTION (EXTENDED-RELEASE) | ADVANZ PHARMA CANADA INC. | MARKETED |
| 02555875 | MYTOLAC | 90 MG | SOLUTION (EXTENDED-RELEASE) | ADVANZ PHARMA CANADA INC. | MARKETED |
| 02283395 | SOMATULINE AUTOGEL | 60 MG | SOLUTION (EXTENDED-RELEASE) | IPSEN BIOPHARMACEUTICALS CANADA INC | MARKETED |
| 02283409 | SOMATULINE AUTOGEL | 90 MG | SOLUTION (EXTENDED-RELEASE) | IPSEN BIOPHARMACEUTICALS CANADA INC | MARKETED |